ASC THERAPEUTICS
ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases. The company was founded in 2008 and is based in Milpitas, California.
ASC THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2008-01-01
Address:
Milpitas, California, United States
Country:
United States
Website Url:
http://www.asctherapeutics.com
Total Employee:
51+
Status:
Active
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS Digital Ocean ATT Barracuda Networks Odoo
Similar Organizations
Angitia Biopharmaceuticals
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.
AUM BioTech
AUM BioTech offers self-delivering Gene silencing products for basic and pre-clinical research.
BiomCare
BiomCare is a company who focuses on the importance of the gut microbiota for human health and well-being.
BiSiChem
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
MandalMed
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Protomer Technologies
Protomer Technologies is a biotechnology company that focuses on metabolic diseases.
Tally Health
Tally Health™ is a biotechnology company founded to change the way we age. Co-founded by longevity expert Dr. David Sinclair.
Current Employees Featured
Official Site Inspections
http://www.asctherapeutics.com
- Host name: 68.183.249.54
- IP address: 68.183.249.54
- Location: Santa Clara United States
- Latitude: 37.3417
- Longitude: -121.9753
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95051
More informations about "ASC Therapeutics"
About Our Company – ADC Therapeutics
Applicants outside of the U.S. must qualify as a charitable organization within the country where they reside. This interactive portal allows you to: 1) provide necessary information so ADCT …See details»
Antibody Drug Conjugates Cancer Treatment – ADC Therapeutics
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025 March 20, 2025; ADC Therapeutics Makes Grants to New Employees …See details»
Our Leadership Team – ADC Therapeutics
US-CORP-NPS-00065 06/24 © 2025 ADC Therapeutics SA. All rights reserved. About ADCT. Overview; Vision and Values; Our Leadership Team; Our Board of DirectorsSee details»
Company: ASC Therapeutics
Company Type: Therapeutic development Main focus: Developing curative treatments for various diseases through a proprietary gene-editing platform, TARGATT™, and other gene-editing …See details»
ADC Therapeutics Announces Abstracts Accepted for Presentation …
3 days ago ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple …See details»
ASC Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
ADC Therapeutics Announces Updated Results from LOTIS-2 Trial …
May 11, 2023 [email protected] +44 7879 627205 Amanda Loshbaugh ADC Therapeutics [email protected] +1 917-288-7023 Media Mary Ann …See details»
ADC Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 908-731-5556 ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing …See details»
Medical Information Hub | ADC Therapeutics | HCP Site
You are now leaving the ADC Therapeutics Medical Information Hub. ADC Therapeutics does not necessarily endorse the organization associated with this link and takes no responsibility for …See details»
ADC Therapeutics Announces Abstracts Accepted for Presentation …
2 days ago /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...See details»
Ameet Mallik, Our Board of Directors – ADC Therapeutics
Ameet Mallik joined ADC Therapeutics as CEO in May 2022. Mr. Mallik has over 25 years of industry experience. Most recently he served as CEO of Rafael Holdings, a novel cancer and …See details»
ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer
Dec 19, 2022 ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of Jose “Pepe” Carmona as Chief Financial Officer (CFO), effective December 19, 2022. He will serve …See details»
ADC Therapeutics Announces Abstracts Accepted for Presentation …
2 days ago ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple …See details»
Antibody Drug Conjugates Clinical Development - ADC Therapeutics
ADCT-602 is an ADC composed of a monoclonal antibody that binds to CD22 conjugated to a PBD–dimer toxin. Once bound to a CD22-expressing cell, ADCT-602 is internalized into the …See details»
ADC Therapeutics Provides Business Updates
Jan 4, 2024 We prioritized our pipeline, strengthened our organization and implemented a disciplined capital allocation model to generate cost efficiencies,” said Ameet Mallik, Chief …See details»
Contact Us - ADC Therapeutics
Report Adverse Reactions or Product Complaints. To report suspected adverse events or product complaints, please call us at 1-855-690-0340 and select prompt 1. You ...See details»
ADC Therapeutics Reports Third Quarter 2023 Financial Results …
Nov 7, 2023 3Q 2023 ZYNLONTA® 1 net sales of $14.3 million reflect disruption following restructuring of commercial organization, increased competition and higher gross-to-net …See details»
GSA eLibrary Contractor Information
A .gov website belongs to an official government organization in the United States. ... [email protected]: Web Address: SAM UEI: Y9MBZX2C5RU5: Socio …See details»
ADC Therapeutics Announces CEO Transition
May 9, 2022 [email protected] +44 7879 627205 Amanda Hamilton ADC Therapeutics [email protected] +1 917-288-7023 USA Media Mary Ann …See details»
Environmental, Social & Governance Report 2021 - ADC …
The organization while keeping our ESG initiatives in mind. I am proud of our accomplishments to date. We are committed to running a sustainable global business, defining our priorities for …See details»